The Role of Potassium-Binding Agents in Treating Hyperkalemia

Video
Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
schizophrenic man - mental disorder - Image credit: Andreza | stock.adobe.com
Related Content
Health care professional holding model of a kidney -- Image credit: benschonewille | stock.adobe.com

Iptacopan Demonstrates 38.3% Proteinuria Reduction in Patients With IgAN

April 24th 2024
Article
Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

March 21st 2024
Podcast
Patient receiving a vaccine -- Image credit: cherryandbees | stock.adobe.com

Recombinant Zoster Vaccine Demonstrates High Protection Against Shingles in Adult Patients

April 24th 2024
Article
Pharmacy Focus: Limited Series - Celebrity Endorsements in Public Health

Pharmacy Focus: Limited Series - Celebrity Endorsements in Public Health

March 20th 2024
Podcast
Image credit: Iliya Mitskavets | stock.adobe.com

Considerations When Treating Migraines in Gender Diverse Patients Receiving Gender-Affirming Hormone Therapy

April 23rd 2024
Article
woman holding hands near head while suffering from headache in bedroom | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com

Migraine Treatment Comes in Different Forms, Allowing for Patient Preference

April 23rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.